Symptom Adapted Therapy in GERD Patients

Clinical trial NCT00343161 · COMPLETED

Trial details

NCT number: NCT00343161
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Gastroesophageal Reflux Disease

Start date: 2006-08-01
Primary completion: 2007-08-01
Enrollment: 441

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.